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Abstract.  Endocytosed Shiga toxin is transported 
from the Golgi complex to the endoplasmic reticulum 
in butyric acid-treated A431 ceils. We here examine 
the extent of this retrograde transport and its regula- 
tion.  The short B fragment of Shiga toxin is sufficient 
for transport to the ER. The B fragment of cholera 
toxin,  which also binds to glycolipids, is transported 
to all the Golgi cisterns,  but cannot be localized in the 
ER even after butyric acid treatment.  Under all condi- 
tions the toxic protein ricin was found predominantly 
in the trans-Golgi network.  There is no transport of 
endocytosed fluid to the Golgi apparatus or to the ER 
even after butyric acid treatment and in the presence 
of Shiga toxin,  indicating that transport to the ER, 
through the trans-Golgi network and the cisterns of 
the Golgi apparatus,  involves several sorting stations. 
Since Shiga toxin receptors (Gb3) in butyric acid- 
treated A431 cells seem to have a  cerarnide moiety 
with longer fatty acids than in untreated cells, the pos- 
sibility exists that fatty acid composition of the recep- 
tor is important for sorting to the ER. Both retrograde 
transport and intoxication with Shiga toxin can also be 
induced by cAMP, supporting the idea that retrograde 
transport from the Golgi to the ER is required for in- 
toxication.  The data suggest that transport to the ER 
in cells in situ may depend on fatty acid composition 
and is regulated by physiological signals. 
A  number of  protein toxins, like Shiga toxin, abrin, ricin, 
~.~  modeccin, pseudomonas toxin,  and cholera toxin, 
•  ]k all consist of a moiety that binds the toxins to cell 
surface receptors, and an enzymatically active moiety that 
acts on cytoplasmic targets (for review, see 42, 46, 80, 83). 
Several  of the protein toxins are transported to the trans- 
Golgi network (TGN) 1 in the cells after endocytic uptake 
from the cell surface, and different lines of evidence suggest 
that this transport is necessary for translocation  of the enzy- 
matically active part of these toxins to the cytosol (22, 23, 
51, 64, 65, 78, 79, 84). Studies of brefeldin A (BFA)-treated 
cells suggest  that there is a correlation between an intact 
Golgi apparatus  and intoxication  (64). Since BFA does not 
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seem to disrupt the TGN in cells (7, 64), one possible expla- 
nation for the protection afforded by BFA could be that these 
toxins  normally  are transported  retrogradely through  the 
Golgi apparatus and to the ER before translocation to the 
cytosol. The mechanism responsible for such a retrograde 
transport is not known.  It has been demonstrated that some 
trans-membrane proteins,  the KDEL receptors, can retain 
newly synthesized proteins with the sequence KDEL in the 
ER, and they can also bring such proteins from the Golgi ap- 
paratus to the ER in a retrograde manner (31). However, sev- 
eral of the protein toxins, including Shiga toxin, do not con- 
taln the KDEL signal (27, 51, 67, 70). It is of course possible 
that the toxins bind to other molecules which are transported 
to the ER. Recent findings supporting the idea that the toxins 
are transported to the ER before translocation is that addition 
of KDEL to ricin increases the toxic effect on cells (82), and 
removal of a KDEL-Iike signal on pseudomonas exotoxin A 
decreases the effect of this toxin (6, 66). Furthermore,  the 
NH2-terminal  region  of pseudomonas toxin may promote 
its own export from microsomes (74). However, not until re- 
cently was an endocytosed ligand seen both in the Golgi ap- 
paratus and in the ER. This was observed for the first time 
in butyric acid-treated  A431 cells (60). After such treatment 
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but also in the various Golgi cisterns, in the ER and in the 
nuclear  envelope.  At the  same time  the  cells became  ex- 
tremely sensitive to this  toxin,  supporting the notion that 
retrograde  transport  is required  for intoxication. 
In the present article we compare the effect of butyric acid 
on intracellular transport  of Shiga toxin with the effect on 
transport  of other toxins (cholera toxin, ricin, and modec- 
cin)  and a  fluid phase marker  (HRP).  We have  tested to 
which extent the butyric acid treatment  affects  retrograde 
transport from the Golgi complex to the ER also of the non- 
toxic Shiga toxin B subunit.  Furthermore, with the idea that 
the composition of glycolipids could be important for sorting 
(81),  we have  analyzed the composition of the Shiga toxin 
receptor in normal A431 cells as well as in cells treated with 
butyric acid. Moreover,  we have studied whether the A431 
cells can be sensitized to Shiga toxin by other types of treat- 
ment than exposure to butyric acid, and whether this sensiti- 
zation is accompanied by retrograde  transport.  As  shown 
here, cAMP can mediate similar changes as butyric acid on 
sensitivity  and  retrograde  transport  of Shiga  toxin,  thus 
strengthening  the notion that these processes are linked, and 
suggesting that retrograde  transport is a process that can be 
regulated also by signals imposed on the cells in situ. 
Materials and Methods 
Reagents 
Type VIA HRP, diaminobenzidine, SPDP (3-[2  pyridyldithio]-propionic 
acid N-hydroxysuccinimideester),  HRP-labeled  cholera toxin B  subunit, 
Hepes, and Tris were obtained from Sigma Chemical Co. (St. Louis, MO). 
We have also used HRP (sp act 938 U/rag) from Serva (Heidelberg,  Ger- 
many). Nycodenz  was obtained from Nycomed Pharma (Oslo,  Norway) 
UDp[3H]galactose,  [3I-I]leucine, Na125I, the kit to measure cAMP,  and 
goat anti-mouse IgG conjugated to 10 um gold were from the Radiochemi- 
cal Centre (Amersham, UK).  Texas red-conjugated  goat anti-mouse IgG 
was obtained from Southern Biotechnology  Associates  (030-07; Birming- 
ham, AL). High performance thin layer chromatography (HPTLC) plates 
coated with Silica Gel 60 either on glass plates or on aluminum sheets were 
purchased  from  Merck  (Darmstadt,  Germany).  Standard  mixtures  of 
pure neutral glycolipids containing Gal/31-1Cer(CMH), Gal/~I-4Glc/31-1Cer- 
(CDH),  Galcd-4Gal/51-4Glc~l-lCer (CTH,  Gb3),  GalNAc/31-3Galcxl-4Oal- 
~l-4Glc/31-1Cer(Gb4),  GalNAccxl-3GalNAc/51-3Oalcd-4Gal/~l-4Glc151-1Cer 
(Forssman pentasaccharide) were from Accurate Chem. & Science Corp. 
(Westhury, NY). Monoclonal antibody raised against globotriose was from 
MonoCarb AB (Lund, Sweden),  and alkaline phosphatase anti-mouse Ig 
was obtained from Sigma Chemical Co. 
Polyisobutylmethacrylate  was obtained from PlcxiGum, Polysciences, 
Inc. (Warrington,  PA). All organic solvents used were of pro analysis from 
Merck. For the autoradingram, X-OMAT x-ray films from Eastman Kodak 
Co.  (Rochester,  NY) were used.  Silica gel and C  18 cartridges  were ob- 
tained from Sep-Pak (Millipore,  Waters Associates,  Milford,  MA). Ricin 
(44) and modeccin (45) were purified as described earlier.  Gelonin was a 
kind gift from Dr. E  Stirpe (Universit~ di Bologna,  Bologna, Italy). Shiga 
toxin and the mutant Shiga-His  (a mutant in which the two Arg between 
A1 and A2 were substituted with His) were provided by Dr. J. V. Kozlov 
(W. A. Engelhardt Institute for Molecular Biology, Academy of Sciences 
of Russia, Moscow, Russia). Shiga toxin subunit B was a generous gift from 
Dr. J. E. Brown (USAMRHD, Frederick, MD). Conjugates of Shige toxin, 
Shiga-His,  Shiga toxin B subunit or ricin and HRP were prepared by the 
SPDP-method  as previously  described (79).  The anti-ER (anti-IP90) anti- 
body AF8 (20) was kindly provided by Dr.  M. B. Brenner (University of 
Pittsburgh, PA). 
Cells 
A431 (human epidermoid carcinoma) cells were from the American Tissue 
Type  Collection  (Rockville,  MD).  The  medium  used  was  Dulbecco's 
modification of Eagle's medium (3.7 g/1 sodium bicarbonate) (Flow Labora- 
tories,  Irvine, Scotland)  containing 5%  fetal calf serum (Gibco,  Ltd., 
Palsly, Scotland)  and 2 mM L-glutamine (Gibco,  Ltd.). 
Measurement of Cytotoxic Effect 
After incubation of cells with toxin as described in legends to figures, the 
medium was removed,  and the cells were incubated in the same medium 
(no unlabeled lencine) for 10 rain at 37°C with 1/zCi of [3H]leucine per 
ml. Then the solution was removed, the cells were washed twice with 5% 
(wt/vol) trichloroacetic acid and solubilized in KOH (0.1 M). Finally, the 
acid-precipitable radioactivity was measured. The experiments were car- 
tied out in duplicate.  The difference between duplicates  was less than 10% 
of the average value. 
Measurement of  Receptor-mediated Binding and 
Endocytosis of~ZJI-Ricin  and lz~I-Modeccin 
Binding and endocytosis of 125I-labeled riein and 125I-modeccin  were mea- 
sured as previously  described (61). 
Measurement of  cAMP 
The content  of  cAMP in  cells  was measured by a cyclic  AMP  [3H]  assay 
system  from  Amcrsliam Corp. In  principle,  2 x  106  cells  growing in  Petri 
dishes  (5-cm diam) were washed twice  in PBS and then  dissolved  in 750 
~I of  ice-cold  HCI (10  raM) in ethanol  (96%). After  5-rain  incubation  at 
0°C, the  cells  were  removed  with  a rubber  policeman and  the  homogenate 
was centrifuged  for 10  rain  in  an Eppendorph centrifuge.  The supernatant 
was freeze-<fried  and the  pellet  was dissolved  in 2 ml KOH (0.2  M). The 
OD (280  nm) of  this  solution  was used  as  a  measurement  of  the  amount  of 
cells  used.  The  freeze-dried  supernatant  was  dissolved  in  250  ~I  Na-acetate 
(0.5  M, pH 6.2).  This solution  was  then  used in  the  Amersham cAMP kit 
to measure the concentration  of  cAMP in the cells. 
SubceUular Fractionation of Polarized Cells 
Incubated with Shiga Toxin 
t251-Shiga toxin (1/~g/ml)  was administered to A431 cells incubated with 
and without 2 mM butyric acid. The toxin was continuously present during 
the incubation, and HRP was usually also added to label endosomal/lysoso- 
real compartments. The fractionation was carried out essentially as described 
by Sandberg et al. (58) who separated rat liver Golgi fractions from the ER. 
The modification  of this method has previously  been described (64). 
Enzyme Analysis 
HRP was measured according to Steinman et al. (68), UDP-galactose:gly- 
copmtein galactosyl  transferase according  to Brfindli et al. (4),  and E-N- 
acetyl-glucosaminidase  according to Beaufay et al. (2). 
Purification of Glycolipids 
Total glycolipids  from A431 cells, grown with and without 2 mM butyric 
acid ('~109 cells,  i.e.,  100 Costar 3000 flasks [225 cm2]) were extracted 
according to methods earlier described (57, 75).  After harvest, the cells 
were pooled and washed in PBS,  suspended  in water and lyophllized.  A 
crude glycolipid  extract was achieved by extracting the dry cell material 
once with 50 ml of chioroform/methanol/water,  20:10:1 by volume over- 
night and then with chloroform/methanol/water,  10:20:1 and 10:10:1 by vol- 
ume. Cell debris was removed by filtration through Whatman filter papers. 
The extracts were pooled and subjected to a mild alkaline bydrolysis with 
0.2 M KOH in methanol for 2 h, thereafter neutralized with glacial acetic 
acid.  Salts were removed through dialysis  against ice-cold water using a 
membrane with tool wt cut off 500 (Spectrapor;  Spectrum Medical Indus- 
tries Inc., Houston, TX), and the material was lyophilized. 
Separation of gangliosides  (acidic glycolipids)  from neutral glycolipids 
was performed as earlier described (72). The samples were dissolved in 90% 
methanol and 10% 5 mM phosphate buffer and passed over a SepPak C18 
(Millipore,  Waters Associates)  cartridge,  equilibrated with methanol (20 
rni) followed by the methanol-phosphate  buffer mixture (10 ml). Acidic gan- 
gliosides  were washed out by adding another 10 ml of the 90% methanol. 
Neutral glycolipids were eluted with 10 ml of pure methanol. The different 
fractions were concentrated and the neutral glycolipids  were additionally 
passed over a Sep-Pak silica cartridge dissolved in chloroform/methanol (1:1 
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Figure 1. Butyric acid-induced sensitization of A431 cells to toxins. 
A431 cells growing in 24-well disposable trays were incubated with 
and without 2  mM butyric acid for the indicated periods of time. 
Then the  cells  were  transferred to  a  Hepes-containing medium 
without serum,  increasing concentrations of toxins were added, 
and the cells were incubated for 3 h more before protein synthesis 
was measured as described in Materials and Methods.  (A) Shiga 
toxin; (B) ricin; (C) modeccin; (o), no butyric acid; (e) butyric 
acid for 3 h; ([]) butyric acid for 17 h; (=), butyric acid for 24 h; 
(zx), butyric acid for 48 h. 
vol/vol).  Further separation of the individual glycolipids  was achieved by 
using HPTLC (57). 
HPTLC Overlay Assay 
Shiga toxin binding to glycolipids on HPTLC plates was performed accord- 
ing to methods described earlier (18, 33).  After separation, the air-dried 
plate was  immersed in 0.05%  polyisobutylmethacrylate in hexane until 
translucency and then thoroughly air-dried. This was repeated three times. 
Unspecific binding sites were blocked by incubating the plate with 1% BSA 
in PBS for 15 min. The plate was then soaked for 1 h in a solution containing 
nSI-labeled Shiga toxin in PBS with 0.05% Tween 20. After washing the 
plate five times in PBS with 0.05 % Tween 20, it was exposed to a X-OMAT 
x-ray film (Eastman Kodak Co.).  Toxin-binding  glycolipids  appeared as 
black bands on the film. A standard of known neutral glycolipids including 
the toxin receptor (Gb3) was used as a control. 
Purification of Toxin Binding Glycolipids 
Preparative HPTLC was used as the final step in purifying toxin-binding 
glycolipids,  which had been identified with the HPTLC overlay described. 
The plates were run on Silica Gel 60 coated on alumina sheets. Gel contain- 
ing the proper bands could then easily be cut out with a scissor and the 
pieces were placed in 5 ml methanol overnight, to extract the glycolipids. 
A final run on a C18 cartridge removed gel remnants. 
Sugar Analysis 
Purified toxin-binding glycolipids  ("01-5 #g, as compared to known Gb3 
standard on HPTLC) were hydrolyzed  with 0.5 ml of 4 M trifluoroacetic 
acid at 98"C for 16 h. The samples were dried and dissolved in 0.5 mi meth- 
anol and dried again. This procedure was repeated three times. Finally the 
samples were dissolved in 100 #1 water, 2  ×  25 #1 were run on a Dionex 
Bio LC-system (Sunnyvale,  CA), and the Millipore calculation program 
Maxima, was used.  Standard Gb3 and a blank were run at the same time. 
Fast Atom Bombardment Mass Spectrometry 
Purified glycolipids,  both native and permethylated derivatives,  were ana- 
lyzed by fast atom bombardment mass spectrometry (FAB MS).  Approxi- 
mately 5  #g of glycolipids,  as estimated from the sugar analysis,  were 
permethylated.  Methylation was  performed  with 4  M  butyUithium  in 
dimethylsulfoxide  with a procedure adjusted for microgram quantities.  The 
sample was dissolved in 200 ~1 DMSO before being sealed and thereafter 
flushed with nitrogen, according to standard methylation procedure.  Butyl- 
lithium (100 #1) was added into the sealed tube, and the content was gently 
mixed.  The vial was left at room temperature for 16 h. After chilling, 200 
#1 of cold methyliodide was added to the sealed tube, the content was gently 
mixed and left at room temperature for 30 rain before the methyliodide was 
evaporated  by flushing  with nitrogen.  The methylated glycolipids  were 
finally purified on a Sep-Pak  C18 cartridge (50). Glycolipids  originating 
from the A431 cell line without butyric acid treatment were analyzed as per- 
methylated derivatives only. FAB MS spectra were recorded on a NERMAG 
R10/10L quadropoule  instrument and on a JEOL SX 102 instrument (JEOL 
U.S.A.  Inc.,  Peabody,  MA).  Ions were produced from a  matrix of tri- 
ethanolamine for native glycolipids  and from a matrix of thioglycerol  or 
m-nitrobenzyl alcohol for permethylated material. 
Processing  for Electron Microscopy 
A431 cells grown as monolayers  in T-25 flasks were treated as described 
in the text, and fixed with 2 % glutaraldehyde  in 0.1 M Na-cacodylate  buffer, 
pH 7.2,  for 60 min at room temperature.  The cells were then carefully 
washed  with PBS and incubated with diaminobenzidine-H202  as previ- 
ously described (79). The cells were posifixed with OsO4, treated with 1% 
uranyl acetate in distilled water, embedded in Epon, cut at 50 rim, and ex- 
amined in a JEOL 100 CX electron microscope without further contrasting 
as previously  described (79). 
Results 
Butyric Acid Induces Sensitization of  A431 Cells to 
Shiga Toxin and Other Protein Toxins 
Untreated A431 cells are resistant to Shiga toxin in spite of 
the fact that the cells are able to bind and endocytose the 
toxin. Endocytosis of Shiga toxin in the untreated cells has 
been shown to occur by EM (60) and cell fractionation as 
well as by quantification of cell surface bound Shiga toxin 
(data not shown). This raises the intriguing question why the 
cells are resistant to Shiga toxin. When A431  cells are in- 
cubated with butyric acid for increasing periods of  time, they 
gradually become sensitive to Shiga toxin (Fig. 1). The cells 
were still resistant after a 3-h incubation with butyric acid, 
they obtained some sensitivity after a  17-h incubation, and 
maximal sensitivity was obtained after 24-48 h. Butyric acid 
had to be present in the medium during the whole incubation 
in order to give maximal sensitivity. When butyric acid was 
removed after 10 h, the cells were completely resistant to 
toxin added after 48 h. Also, when  butyric acid was removed 
after 48 h, the cells again became resistant to Shiga toxin 
(data not shown). 
The sensitization to Shiga toxin is dependent on protein 
synthesis. When cycloheximide was added at the same time 
as butyric acid, the cells remained resistant to Shiga toxin 
(data not shown), demonstrating that it is not the presence 
of butyric acid as such that makes the cells sensitive. Cyclo- 
heximide reversibly inhibits protein synthesis, and the effect 
of Shiga toxin could therefore be measured upon removal of 
cycloheximide. Similarly, as found for Shiga toxin, although 
not to the same extent, the A431 cells were sensitized by bu- 
tyric acid also to ricin and modeccin (Fig.  1). The binding 
and endocytosis of these toxins were unaffected by the bu- 
tyric acid treatment (data not shown). In A431 cells (data not 
shown) and in some other cell types (41, 48),  BFA com- 
pletely  inhibits cholera toxin-induced increase  in  cAMP, 
suggesting that Golgi is involved also in the entry of this 
toxin. However, the ability of cholera toxin to raise the level 
of cAMP was not increased in the butyric acid-treated cells. 
Sandvig et al. Retrograde Transport to the ER  55 Figure 2.  Retrograde transport of Shiga B fragment to the endoplasmic reticttlum. A431  cells were incubated with 2 mM butyric acid 
for 48 h at 37°C and then with Shiga B-HRP for 1 h at 37°C. The cells were then processed for diaminobenzidine cytochemistry to detect 
the toxin conjugate in the ER, which sometimes forms characteristic whorls (A). Alternatively, cryosections of ceils were incubated with 
the anti-IP90 monoclonal antibody AF8 followed by goat anti-mouse IgG conjugated to 10 nm gold (B, arrows) to detect ER cisterns (B). 
C is a corresponding immunofluorescence picture to show AFS-labeling of the ER and nuclear envelope. AF8 was detected with Texas 
red-conjugated goat anti-mouse IgG. Bars; (/1 and B) 0.5/zm,  (C) 5/zm. Figure 3.  The ER labeling with Shiga-HRP varies considerably. A431 cells were incubated with butyric acid as in Fig. 2 and then they 
were incubated with Shiga-HRP 0aolotoxin) (A) or Shiga B-HRP (B-D) for 1 h. The toxin labeling (diaminobenzidine reaction product) 
varies considerably from ER cistern to cistern or even within the same ER cisterns (A and B) as well as from cell to cell (C and D). 
In A and B, small arrows indicate distinctly labeled portions of ER cisterns whereas open arrows indicate portions with very tittle or appar- 
ently no Shiga labeling. In C and D  is shown how the ER and nuclear envelope (Ne) can be heavily labeled in some cells while these 
structures may appear unlabeled even in neighboring ceUs. Bars; (.4 and B) 0.5/~m; (C and D)  1 ~m. 
Sandvig et al. Retrograde Transport to the ER  57 Figure 4. Endocytosed cholera-B-HRP is found throughout the Golgi apparatus but cannot be detected in the ER even after butyric acid 
treatment.  A431 ceils without (A) or with (B) a 48-h preincubation with butyric acid were incubated for 1 h at 37"C with a conjugate 
of HRP and cholera toxin B fragment. Even though reaction product is distinct in endosomes/lysosomes (EL) and in the Golgi complexes 
(Go), where it often labels all cisterns from one side to the other (small arrows), it was never detected in the ER nor in the nuclear envelope 
(Ne). M, mitochondria.  Bar, 0.5/~m. 
Butyric acid treatment of  A431 cells likewise had no sensitiz- 
ing effect to gelonin (an A-chain-like toxin which does not 
bind to cells) (69) or to diphtheria toxin which is believed 
to enter the cytosol from early endosomes (13, 62). 
Butyric Acid Induces Retrograde  Transport of  Shiga 
Toxin and Shiga B Fragment to the ER 
Previous studies have suggested that Shiga toxin has to be 
transported to the Golgi apparatus before being translocated 
to the cytosol (63-65). Also in butyric acid-treated cells this 
seemed to be the case. When transport through the Golgi ap- 
paratus was interrupted by addition of the drug BFA, there 
was no effect of Shiga toxin in the butyric acid-treated cells 
(59).  Interestingly, Shiga-HRP was never observed in the 
ER after BFA treatment (not shown). Also, Shiga toxin did 
not inhibit the protein synthesis in butyric acid-treated cells 
when added to cells at 18°C, a temperature at which trans- 
port to the Golgi apparatus is inhibited (76).  Furthermore, 
the time between addition of toxin and the inhibition of pro- 
tein synthesis was '~30 min, a lag time previously found in 
cell lines that are normally sensitive. The results thus suggest 
that the toxin follows the same pathway in the butyric acid- 
treated cells as in cell lines that are normally sensitive to the 
toxin. 
To  investigate  whether  retrograde  transport  to  the  ER 
somehow could be dependent on the A  fragment of Shiga 
Figure 5. Autoradiogram show- 
ing  binding  of  125I-labeled 
Shiga  toxin  to  glycolipids. 
Neutral glycolipids were sep- 
arated by HPTLC in the sol- 
vent system chloroform/meth- 
anol/water  60:35:8  (vol/vol/ 
vol).  The chromatogram was 
treated with 0.05 % polyisobu- 
tylmethacrylate in hexane 3 × 
1 min, followed by incubation 
in PBS supplemented with 1% 
BSA and 0.05 % Tween 20 for 
15 min. The plate was then in- 
cubated with 100 m120 #g/ml 
12SI-labeled Shiga toxin  (280 
cpm/ng)  for  1  h,  washed  5 
times with 0.05 % Tween 20 in 
PBS,  air-dried,  and  exposed 
to Kodak X-OMAT x-ray film 
for 24 h.  The procedure  was 
performed at room tempera- 
rare. Standard mixture of neu- 
trai  glycolipids  containing 
monohexoside  (CMH), gaia- 
biosylceramide (CDH), globotriaosylceramide  (CTH), Globoside 
(Gb4) and Forssman pentasaccharide  (lane 1), neutral glycolipids 
from A431 cells (lane 2) and from butyric acid-treated A431 cells 
(lane 3). 
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Figure 6. Negative ion FAB MS spectrum of Shiga toxin-binding 
glycolipids from butyric acid-treated A431 cells, native material. 
Molecular ions at m/z 1023 and 1133/1135 are observed. The frag- 
ment ions m/z 861, 699, 537 and m/z 971, 809, 647 confirmed that 
the  major glycolipids contained three hexoses and a  ceramide 
group. Fragment ions at m/z 398, 426, 452/454, and 482 are pro- 
posed to be derived from hex3-ceramides with short fatty acids 
(C6-C12). 
toxin, we next tested whether the small B fragment of Shiga 
toxin alone also could be transported via the Golgi complex 
to the ER by using a Shiga B-HRP conjugate. As shown in 
Fig. 2, this was clearly the case. Since we were unable to 
detect Shiga toxin in the ER by immunogold labeling of 
ultracryosections, we documented that cisterns similar to the 
Shiga B-HRP-labeled cisternal structures were actually ER 
cisterns by immunogold labeling with the anti-ER antibody 
AF8 on ultracryosections (Fig. 2). While the labeling of ER 
cisterns with Shiga-HRP or Shiga-B-HRP was sometimes 
very heavy, a lower degree of  labeling was often seen. Hence, 
in most cells only a few ER cisterns, or portions of cisterns, 
were distinctly labeled, the others appeared unlabeled. Also, 
apparently unlabeled ER cisterns could be observed in ceils 
next to other cells with heavily labeled ER and nuclear enve- 
lope (Fig. 3). 
The efficient retrograde transport observed for Shiga toxin 
in butyric acid-treated cells did not seem to be general for 
all ligands transported to the Golgi apparatus. Thus, we were 
not  able  to  visualize  retrograde  transport  of ricin-HRP, 
which could only or predominantly be observed in the TGN 
(76-79).  Cholera B-HRP, a lipid-binding ligand with spec- 
ificity for GM1  (15), showed a  different labeling pattern. 
Both with and without butyric acid treatment, this ligand 
gave a very pronounced staining of  the Golgi complexes, and 
the label was often present on both sides (cis-trans) of the 
stacks. However,  no labeling of the endoplasmic reticulum 
or the nuclear envelope was seen (Fig. 4). 
lntraceUular Transport of the Fluid-phase Marker 
HRP in Butyric Acid-treated Cells 
We were also interested in testing whether the fluid phase 
marker HRP was transported to the Golgi apparatus and fur- 
ther backwards to the ER in butyric acid-treated cells. As 
earlier observed in other cell types (for review, see 77), we 
could not see transport of HRP to the Golgi apparatus in 
A431 cells even after butyric acid treatment. Furthermore, 
no HRP was observed in the endoplasmic retlculum (not 
shown), The possibility existed that addition of Shiga toxin 
could lead to a reroutlng of fluid in the butyric acid-treated 
A431 cells. However, even when unlabeled Shiga toxin was 
added together with HRP, this compound could not be ob- 
served in the Golgi apparatus or the endoplasmic reticulum. 
Purification and Characterization of  Shiga 
Toxin Receptors 
Since butyric acid-induced retrograde transport  could be 
demonstrated only for Shiga toxin which binds to neutral 
glycosphingolipids with the  sequence  galcd-4galB  (9,  21, 
32), we decided to analyze whether butyric acid treatment 
caused any changes in the composition of the Shiga toxin 
receptors. For this purpose, glycosphingolipids from a large 
number of cells (109 cells) cultured with and without bu- 
tyric acid were prepared and separated with HPTLC. Toxin- 
binding glycolipids were identified by overlaying the chro- 
matogram with 125I-labeled Shiga toxin. As shown in Fig. 5, 
both untreated and butyric acid-treated A431  cells contain 
neutral glycolipids that bind Shiga toxin in a HPTLC overlay 
system. The butyric acid-treated A431  cells contain three 
closely migrating bands with affinity for Shiga toxin. The 
upper band is close to the position for the standard Gb3, 
which is the main toxin-binding glycolipid in the standard 
mixture of glycolipids. On the other hand, untreated A431 
cells contain one main glycolipid with affinity for the toxin, 
and a hardly discernible band corresponding to the middle 
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Figure 7. Sensitization of A431 cells to Shiga toxin by 8-Br-cAMP 
treatment. A431 cells were incubated with and without 8-Br-cAMP 
(2 raM) for 48 h. Then increasing concentrations of Shiga toxin 
were added, and the protein synthesis was measured 3 h later as 
described in Materials and Methods. 
band found in butyric acid-treated cells. The main band in 
the untreated A431 cells has a low migration rate, suggesting 
a content of short fatty acids (see below). In the standard 
mixture of glycolipids,  also  G1M, which  has  an  internal 
galcfl-4gal/L sequence shows a very weak affinity for 125I- 
labeled Shiga toxin. When the HPTLC was overlaid with 
monoclonal antibodies recognizing galcd-4gal~-4glc, only 
the two upper bands in the butyric acid treated cells were re- 
vealed (data not shown), a finding that could be due to low 
affinity of the antibody to carbohydrates coupled to cera- 
mides with short fatty acids (see Discussion). The HPTLC 
overlay assay clearly shows that butyric acid changes the 
composition of the Shiga toxin-binding sites in A431 cells. 
Structural  information on the toxin-binding glycolipids 
was obtained by sugar analysis and FAB MS. Toxin-binding 
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Figure 8. Effect of cholera toxin treatment of A431 cells on the sen- 
sitivity to Shiga toxin. A431 cells growing in 24-well plates were 
incubated for 48 h with and without cholera toxin (2 ttg/ml), chol- 
era toxin B subunit (2 ttg/ml) or butyric acid (b.a. ; 2 raM). Then 
increasing concentrations of Shiga toxin were added, and the pro- 
tein synthesis was measured after 3 h as described under Materials 
and Methods. 
glycolipids from closely migrating bands  on the HPTLC 
were extracted and  analyzed together.  Sugar  analysis  re- 
vealed identical patterns  of glucose and  galactose  in the 
preparations from both untreated and butyric acid-treated 
A431 cells as well as from standard Gb3. No other sugar res- 
idue was detected. The FAB MS spectrum of underivatized 
glycolipids from butyric acid-treated A431 cells, run in the 
negative mode, demonstrated molecular ions at m/z  1023 
and 1133/1135 (Fig. 6). The fragment ions m/z 861, 699, 537 
and m/z 971, 809, 647, originating from the loss of hexose 
residues (162 mass units), confirmed that the major glyco- 
lipids contained three hexoses and a ceramide group. Frag- 
ment ions at m/z 398, 426, 452/454, and 482 are proposed 
to be derived from hex3-ceramides with short fatty acids 
(C6-C12). Their molecular ions were not detected in these 
spectra. 
The data suggest that the ceramide of the lower molecular 
weight glycolipid (m/z 1023, middle band in HPTLC, Fig. 
5) is composed of either a C18:0 base with C16:1 fatty acid 
or a C18:1 base with a C16:0 fatty acid. The glycolipid of 
higher molecular weight is assumed to be composed of a 
C18:1 base with C24:1/C24:0 fatty acids. Permethylation of 
the material implies exchange of all OH- and Nil- groups to 
O-methyl- and N-methyl groups, respectively. The FAB MS 
spectrum of permethylated samples (data not shown), run in 
the positive mode, demonstrated sodiated molecular ions at 
m/z 1325/1327 and 1215. This represents an addition of 12 
methyl groups to m/z 1133/1135 and 1023 upon methylation. 
Two methyl groups belong to the ceramide and 10 methyl 
groups belong to the three hexoses, thus indicating that the 
ceramide part of the glycolipids has one hydroxyl group. We 
also observed in this spectrum a molecular ion at rn/z 1104 
which is assumed to correspond to a hex3-ceramide with a 
C18:0 base and a C8:0 fatty acid. The spectra of  the two lipid 
preparations revealed the same ions, indicating the presence 
of the same glycolipids. However, the intensities of the ions 
differed. In A431 cells the molecular ions corresponding to 
the hex3-ceramides with short-chain fatty acids were much 
more  abundant  than  those  corresponding  to  the  hex3- 
ceramides with longer fatty acids, which were almost absent. 
This is in agreement with the HPTLC autoradiogram, where 
....  .o  ,  4,  , 
400 
~  30o 
E 
100  b.a. 
Time (h) 
Figure 9.  Effect of butyric acid and cholera toxin on the level of 
cAMP in A431 cells. A431 cells were incubated with and without 
butyric acid (b.a. ; 2 mM) or cholera toxin (2/~g/ml). Afte  r increas- 
ing periods of time the ceils were harvested for analysis of cAMP 
as described under Materials and Methods. 
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the glycolipids with the short fatty acids. 
Cholera Toxin and cAMP Sensitize,4431 Cells to Shiga 
Toxin and Induce Retrograde Transport 
Since butyric acid is known to cause differentiation of cells 
(8,  30,  34),  we tested whether other differentiating agents 
(25, 26, 36, 43, 53) could sensitize A431 cells to Shiga toxin. 
Neither retinoic acid (10-5-5  ×  10  -5 M), DMSO (1%), TPA 
(0.1-1000 ng/ml), TNFa (10-1000 ng/ml), nor vitamin D (10 
nM-10  #M)  had  any  sensitizing  effect (data  not  shown). 
Since dibutyryl-cAMP has been used to induce differentia- 
tion of HL60 cells (26,  30),  we tested whether 8-Bromo- 
adenosine-3'5'-cyclic monophosphate  (8-Br-cAMP)  could 
sensitize A431 cells to Shiga toxin. We did not use dibutyryl- 
cAMP since butyric acid in itself sensitizes the A431 cells. 
As shown in Fig. 7, incubation of cells with 8-Br-cAMP had 
a strong sensitizing effect. Also, as shown in Fig. 8, incuba- 
tion of A431 cells with cholera toxin made the ceils sensitive 
to Shiga toxin, and as shown in Fig. 9, cholera toxin, in con- 
trast to butyric acid, strongly increased the level of cAMP 
in these cells. Cholera toxin B subunit alone was without any 
effect. Similarly as found for butyric acid-induced sensitiza- 
tion, a long incubation (48 h) in the presence of 8-Br-cAMP 
or cholera toxin was required to obtain maximal sensitivity 
to  Shiga  toxin,  and,  as  also  found  for the butyric acid- 
induced sensitization, presence of cycloheximide during the 
48 h prevented the cells from becoming sensitive, suggesting 
that protein synthesis is required for the sensitization (data 
not shown). Also in these experiments cycloheximide  was re- 
moved before the sensitivity of the ceils to the toxin was 
tested.  Electron microscopy of 8-Br-cAMP-treated A431 
cells incubated with HRP conjugated to Shiga toxin or to a 
mutant of Shiga toxin (see Materials and Methods) revealed 
distinct labeling of ER cisterns in some cells (Fig.  10). 
Discussion 
The results described here show that retrograde transport of 
Shiga toxin to the endoplasmic reticulum is a process that 
Figure 10. cAMP induces retrograde transport of Shiga toxin to the ER. A431 cells were incubated with 2 mM 8-Br-cAMP for 48 h at 
37°C and then with a Shiga (His-mutant)-HRP  conjugate for 75 min at 37°C before fixation and processing for EM. The toxin is seen 
on the cell surface (Cs), in the intracellnlar spaces (Is) of overlapping cells, and in ER cisterns. Note the apparently unlabeled ER cistern 
(open arrows) in A. Bars, 0.5 gm. 
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of  physiologically  active ligands are able to increase the con- 
centration of cAMP in cells (73), and it is therefore possible 
that a change in retrograde transport could be part of  a physi- 
ological response. Interestingly, it was recently reported that 
constitutive secretory traffic can be modulated by membrane 
receptors and second messengers (12),  suggesting that net 
retrograde transport could be affected also by a regulation of 
the rate of secretion. 
Butyric acid is able to change gene transcription in a num- 
ber of cells (3,  16, 17, 49, 55, 56), and exposure of cells to 
butyric acid does occur also in vivo. The concentration of 
butyric acid in the intestine varies, but can be •20  mM (19), 
a concentration that might certainly affect the epithelial cells 
in the intestine. Whether this exposure will change retro- 
grade transport in these cells and thereby sensitize them to 
Shiga toxin, thus making a person more susceptible to dis- 
ease  during  infection  with  E.  coli-producing  Shiga-like 
toxins, is an open question. Intestinal cells can clearly be 
sensitive to Shiga toxin (40, 42). However, although human 
colonic and ileal epithelial cells in primary culture are sensi- 
tive to the toxin (40), it is not known to which extent these 
cells are influenced by agents they have been exposed to be- 
fore the isolation. On the other hand, two human colonic car- 
cinoma cell lines, polarized CaCo-2 cells grown on filters 
and T-84 ceils, are quite resistant to Shiga toxin (reference 
35 and unpublished data). The production of butyric acid 
from dietary fiber may, on the other hand, protect against co- 
lon cancer (8, 34). 
Incubation of A431 cells with cholera toxin sensitized the 
cells to Shiga toxin. However,  since cholera-B in some sys- 
tems has physiological effects that are independent of cAMP 
(37), we checked that cholera-B was unable to sensitize the 
ceils to Shiga toxin. Since also 8-Br-cAMP had a sensitizing 
effect, we believe that increased levels of  cAMP are responsi- 
ble for the observed sensitization to Shiga toxin also after in- 
cubation with cholera toxin. 
Not only Shiga toxin, but also the B fragment alone, could 
be transported to the ER. Although the B fragment does not 
contain a KDEL sequence (26, 67, 70), it may contain an- 
other signal of importance for retrograde transport.  How- 
ever, it is possible that the receptors themselves, even in the 
absence of toxin, are transported from the Golgi to the ER 
after treatment with butyric acid and CAMP. Of the ligands 
here tested we can visualize only Shiga toxin and the binding 
subunit (the B fragment) of this toxin in the ER. As shown 
in the present study butyric acid treatment caused a dramatic 
change in the fatty acid composition of  the Shiga toxin recep- 
tor, Gb3 (9, 21, 32).  The data suggest that the butyric acid- 
treated cells contain Gb3 with longer fatty acid chain lengths 
than the untreated cells, and this change in receptor compo- 
sition may be important for the observed retrograde trans- 
port  in butyric acid-treated cells.  It has previously been 
reported that variations in the ceramide composition can 
affect sphingolipid sorting in epithelial cells (81).  Changes 
in the fatty acid chain in glucosylceramide and sphingomye- 
lin affected the apical to basolateral polarity of these mole- 
cules in MDCK and Caco-2 cells. Similarly, ceramide com- 
position might affect sorting also from the cell surface to the 
Golgi apparatus and to the ER. Not only could the interac- 
tion of the receptor with other molecules in the lipid bilayer 
be changed, but also the interaction of the glycosphingolipid 
sugar moiety (and bound Shiga toxin) with other molecules 
at the cell surface could be different since long fatty acids in 
the ceramide moiety seem to increase the surface exposure 
of the carbohydrate chain (10). Antibodies with low affinity 
can recognize a glycolipid incorporated into liposomes when 
the fatty acid chain length is increased (10), and the ceramide 
composition also influences the anfigenicity  of glycolipids in 
lymphoma cells (24).  Furthermore, in studies where mam- 
malian glycolipids were separated by HFrLC or microtiter 
wells were coated with glycolipids, it was shown that the cer- 
amide composition of lactosylceramide is important for rec- 
ognition of different subspecies of Propionobacterium (71). 
Also, other studies indicate that lipid composition may affect 
carbohydrate conformation on TLC (52).  An effect of the 
lipids on the carbohydrate presentation could be the reason 
why the antibody to galod-4gal/31-4glc only recognized the 
upper two of the three bands recognized by Shiga toxin on 
the HPTLC. The sugar analysis excluded that the lower band 
contains other sugars than galactose and glucose, and the 
possibility  that  the  lowest  band  contains  a  four-bexose 
glycolipid is unlikely since a third molecular ion would then 
have been detected in the FAB  MS.  Also,  a  four-hexose 
glycolipid would migrate even slower on HPTLC (32).  Al- 
though at the present time we can not conclude that a change 
in lipid composition is responsible for the retrograde trans- 
port of Shiga toxin, it is certainly a possibility which should 
be tested in future studies. 
It is difficult to make any absolute statements about the 
generality of the retrograde transport. Ricin-HRP may not 
be detectable in the ER due to a low concentration of  the con- 
jugate. Although the effect on sensitivity to ricin is much 
smaller than the sensitization to Shiga toxin, butyric acid 
treatment makes the cells more sensitive also to this toxin. 
It should be noted that ricin binds to both glycoproteins and 
glycolipids with terminal galactose (46), and a changed rout- 
ing of glycolipids might therefore also affect ricin toxicity. 
Similarly to ricin, modeccin also binds to both glycoproteins 
and glycolipids with terminal galactose, although this toxin 
binds to a subgroup of the ricin-binding sites at the cell sur- 
face (46). Thus, a change in the binding sites might therefore 
also explain the increased toxicity of this molecule. It should 
be stressed that the peroxidase technique is not a quantitative 
approach.  However,  under the actual experimental condi- 
tions where only relatively small amounts of toxin may be 
transported retrogradely, the peroxidase technique appears 
more sensitive than immunogold labeling on ultracryosec- 
tions (we have so far been unable to detect retrograde toxin 
transport to the ER convincingly with the latter approach). 
The fact that the protein synthesis is completely inhibited 
in A431  cultures after butyric acid treatment and exposure 
to high concentrations of Shiga toxin suggests that if translo- 
cation to the ER is required for intoxication, Shiga toxin is 
present in the ER cisterns of virtually all cells even though 
the toxin is morphologically detectable only in a fraction of 
the cells. Thus, it is possible that also cholera toxin B, al- 
though not visible in the ER, could be present at low concen- 
trations. It is remarkable that all Golgi cisterns are often 
distinctly labeled by cholera-B-HRP without any visible re- 
action product in the ER. If  the volume of  the ER is consider- 
ably larger than that of the Golgi apparatus, one could get 
a dilution of conjugates transported retrogradely, thus mak- 
ing visualization more difficult or even impossible. It has 
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were  unstained  by  a  cholera  toxin  conjugate  (22,  23). 
Whether this is due to the cell type studied is not clear. 
The  fact  that  BFA  inhibits  appearance  of  the  Shiga 
toxin-HRP conjugate in the ER, suggests that there is no di- 
rect transport of Shiga toxin to the ER from the cell surface. 
Also, if there had been a direct route from the cell surface 
to the ER in the butyric acid-treated  cells, one would expect 
to see transport also of fluid phase markers (HRP) to the ER. 
This was however not the case, supporting the view that the 
regulated retrograde transport to the ER occurs via the Golgi 
apparatus. 
There is a large variation  in the sensitivity of cells to pro- 
tein toxins (for review, see 46).  This can in some cases be 
explained by a variation  in the number of receptors for the 
toxin at the call surface. However, in the case of Shiga toxin, 
several cell lines are almost resistant to the toxin in spite of 
being able to bind the toxin (14,  60).  We have  shown that 
not only do A431 ceils bind the toxin, they also endocytose 
the toxin. One possible explanation for the variation in sensi- 
tivity between cell lines could be that there is a different ex- 
tent of retrograde  transport in these cells. In spite of the in- 
creasing evidence  for a  link between retrograde  transport 
and the transport of some of the protein toxins to the cytosol, 
it is still premature  to conclude that transport  to the ER is 
an obligatory step for intoxication. Recently Bau and Draper 
(1) showed that call mutants having  an aberrant Golgi com- 
plex were still intoxicated with ricin. On the basis of these 
studies, they suggested that ricin entry into the cytosol might 
be  independent  on  transport  through  the  Golgi  stacks. 
Clearly more work is required to clarify these questions. 
By  learning more about factors that are involved in the 
regulation of retrograde transport we might be able to modu- 
late the intracellular transport not only of protein toxins, but 
perhaps also of immunotoxins (47) and molecules of physio- 
logical importance, like growth factors (5,  38, 54,  85) and 
cytokines (11, 28, 29,  39),  which in some cases also seem 
to be translocated to the cytosol and the nucleus in the cell. 
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